Current Guidelines and Standards of Practice for Restless Legs Syndrome

American Journal of Medicine

Volumn 120, Issue 1 SUPPL. 1, 2007, Pages

  Hening, Wayne A ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Anticonvulsants; Dopaminergics; Opioids; Restless legs; Sedative hypnotics; Treatment

Indexed keywords

ASCORBIC ACID; BENSERAZIDE; CARBAMAZEPINE; CARBIDOPA; CLONAZEPAM; CODEINE; DEXTROPROPOXYPHENE; DOPAMINE RECEPTOR STIMULATING AGENT; FERROUS SULFATE; FLURAZEPAM; GABAPENTIN; HYDROCODONE; HYPNOTIC SEDATIVE AGENT; LEVODOPA; METHADONE; OXYCODONE; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; TRAMADOL;

ARTICLE; BEHAVIOR THERAPY; DISEASE SEVERITY; HUMAN; HYGIENE; LIFESTYLE MODIFICATION; LOW DRUG DOSE; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SLEEP; STANDARD; SUPPORT GROUP;

ALGORITHMS; ANALGESICS, OPIOID; ANTICONVULSANTS; DOPAMINE AGENTS; HUMANS; HYPNOTICS AND SEDATIVES; IRON; LIFE STYLE; PRACTICE GUIDELINES; RESTLESS LEGS SYNDROME; RISK REDUCTION BEHAVIOR; SLEEP;

EID: 33845764382     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.11.004     Document Type: Article

References (44)

1. Chesson Jr. A.L., Wise M., Davila D., et al., Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine Report. Sleep 22 (1999) 961-968
2. Hening W., Allen R., Earley C., Kushida C., Picchietti D., and Silber M. The treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine Review. Sleep 22 (1999) 970-999
3. Littner M.R., Kushida C., Anderson W.M., et al. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 27 (2004) 557-559
4. Hening W.A., Allen R.P., Earley C.J., Picchietti D.L., and Silber M.H. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 27 (2004) 560-583
5. Silber M.H., Ehrenberg B.L., Allen R.P., et al. An algorithm for the management of restless legs syndrome. Mayo Clin Proc 79 (2004) 916-922
6. Gunzel J. Restless Legs Syndrome: The RLS Rebel's Survival Guide (2006), Wheatmark, Inc, Tucson, AZ
7. Earley C.J., and Allen R.P. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep 19 (1996) 801-810
8. Ondo W.G. Methadone for refractory restless legs syndrome. Mov Disord 20 (2005) 345-348
9. Earley C.J. Restless legs syndrome. N Engl J Med 348 (2003) 2103-2109
10. Vignatelli L., Billiard M., Clarenbach P., et al. for the EFNS [European Federation of Neurological Societies] Task Force. Eur J Neurol 13 (2006) 1049-1065
11. Stiasny-Kolster K., Kohnen R., Schollmayer E., Moller J.C., and Oertel W.H. Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study. Mov Disord 19 (2004) 1432-1438
12. Walters A.S., Hening W.A., Kavey N., Chokroverty S., and Gidro-Frank S. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol 24 (1988) 455-458
13. Trenkwalder C., Hundemer H.P., Lledo A., et al., PEARLS Study Group. Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS [Pergolide European Australian RLS] study. Neurology 62 (2004) 1391-1397
14. Serratrice J., Disdier P., Habib G., Viallet F., and Weiller P.J. Fibrotic valvular heart disease subsequent to bromocriptine treatment. Cardiol Rev 10 (2002) 334-336
15. Lanier W.L. Additional insights into pergolide-associated valvular heart disease. Mayo Clin Proc 78 (2003) 684-686
16. Agarwal P., Fahn S., and Frucht S.J. Diagnosis and management of pergolide-induced fibrosis. Mov Disord 19 (2004) 699-704
17. Stiasny-Kolster K., Benes H., Peglau I., et al. Effective cabergoline treatment in idiopathic restless legs syndrome. Neurology 63 (2004) 2272-2279
18. Horvath J., Fross R.D., Kleiner-Fisman G., et al. Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists. Mov Disord 19 (2004) 656-662
19. Walters A.S., Ondo W.G., Dreykluft T., Grunstein R., Lee D., Sethi K., and Treat RLS 2 (Therapy with Ropinirole: Efficacy And Tolerability in RLS 2) Study Group. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord 19 (2004) 1414-1423
20. Silber M.H., Girish M., and Izurieta R. Pramipexole in the management of restless legs syndrome: an extended study. Sleep 26 (2003) 819-821
21. Winkelman J.W., and Johnston L. Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS). Sleep Med 5 (2004) 9-14
22. Tribl G.G., Sycha T., Kotzailias N., Zeitlhofer J., and Auff E. Apomorphine in idiopathic restless legs syndrome: an exploratory study. J Neurol Neurosurg Psychiatry 76 (2005) 181-185
23. Benes H. Transdermal lisuride: short-term efficacy and tolerability study in patients with severe restless legs syndrome. Sleep Med 7 (2006) 31-35
24. Walters A.S., Wagner M.L., Hening W.A., et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 16 (1993) 327-332
25. Walters A.S., Winkelmann J., Trenkwalder C., et al. Long-term follow-up on restless legs syndrome patients treated with opioids. Mov Disord 16 (2001) 1105-1109
26. Jakobsson B., and Ruuth K. Successful treatment of restless legs syndrome with an implanted pump for intrathecal drug delivery. Acta Anaesthesiol Scand 46 (2002) 114-117
27. Lauerma H., and Markkula J. Treatment of restless legs syndrome with tramadol: an open study. J Clin Psychiatry 60 (1999) 241-244
28. Telstad W., Sørensen O., Larsen S., Lillevold P.E., Stensrud P., and Nyberg-Hansen R. Treatment of the restless legs syndrome with carbamazepine: a double blind study. BMJ 288 (1984) 444-446
29. Garcia-Borreguero D., Larrosa O., de la Llave Y., Verger K., Masramon X., and Hernandez G. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 59 (2002) 1573-1579
30. Happe S., Sauter C., Klosch G., Saletu B., and Zeitlhofer J. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Neuropsychobiology 48 (2003) 82-86
31. Ehrenberg B.L., Eisensehr I., Corbett K.E., Crowley P.F., and Walters A.S. Valproate for sleep consolidation in periodic limb movement disorder. J Clin Psychopharmacol 20 (2000) 574-578
32. Youssef E.A., Wagner M.L., Martinez J.O., and Hening W. Pilot trial of lamotrigine in the restless legs syndrome [letter]. Sleep Med 6 (2005) 89
33. Matthews W.B. Treatment of restless legs syndrome with clonazepam [letter]. BMJ 1 (1979) 751
34. O'Keeffe S.T., Gavin K., and Lavan J.N. Iron status and restless legs syndrome in the elderly. Age Ageing 23 (1994) 200-203
35. Earley C.J., Heckler D., and Allen R.P. The treatment of restless legs syndrome with intravenous iron dextran. Sleep Med 5 (2004) 231-235
36. Earley C.J., Heckler D., and Allen R.P. Repeated IV doses of iron provides effective supplemental treatment of restless legs syndrome. Sleep Med 6 (2005) 301-305
37. O'Keeffe S.T. Iron deficiency with normal ferritin levels in restless legs syndrome. Sleep Med 6 (2005) 281-282
38. Wagner M.L., Walters A.S., Coleman R.G., Hening W.A., Grasing K., and Chokroverty S. Randomized, double-blind, placebo-controlled study of clonidine in restless legs syndrome. Sleep 19 (1996) 52-58
39. Manconi M., Ferini-Strambi L., and Hening W.A. Response to Clinical Corners case (Sleep Medicine 6/2: 83-4): pregnancy associated with daytime sleepiness and nighttime restlessness. Sleep Med 6 (2005) 477-478
40. Walters A.S., Mandelbaum D.E., Lewin D.S., Kugler S., England S.J., Miller M., and Dopaminergic Therapy Study Group. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Pediatr Neurol 22 (2000) 182-186
41. Manconi M., Govoni V., De Vito A., et al. Restless legs syndrome and pregnancy. Neurology 63 (2004) 1065-1069
42. Winkelmann J., Stautner A., Samtleben W., and Trenkwalder C. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation. Mov Disord 17 (2002) 1072-1076
43. Hening W.A. Subjective and objective criteria in the diagnosis of the restless legs syndrome. Sleep Med 5 (2004) 285-292
44. Paulus W., and Trenkwalder C. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol 5 (2006) 878-886